An immobilization-free electrochemical biosensor based on CRISPR/Cas13a and FAM-RNA-MB for simultaneous detection of multiple pathogens
Biosensors and Bioelectronics · 2023
DOI: 10.1016/j.bios.2023.115673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023. Verfasst von Jinying Dong und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Biochemical Engineering, PLA Key Laboratory of Biopharmaceutical Production & Formulation Engineering, Institute of Proces…. Hauptthemen laut MEDLINE: Biosensing Techniques, CRISPR-Cas Systems, Electrochemical Techniques, Bacteria. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Biochemical Engineering, PLA Key Laboratory of Biopharmaceutical Production & Formulation Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, 100190, China; Un…
Zitieren
APA
Dong, J., Wu, X., Hu, Q., Sun, C., Li, J., Song, P., Su, Y., & Zhou, L. (2023). An immobilization-free electrochemical biosensor based on CRISPR/Cas13a and FAM-RNA-MB for simultaneous detection of multiple pathogens. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115673
Vancouver
Dong J, Wu X, Hu Q, Sun C, Li J, Song P, et al. An immobilization-free electrochemical biosensor based on CRISPR/Cas13a and FAM-RNA-MB for simultaneous detection of multiple pathogens. Biosensors and Bioelectronics. 2023. doi:10.1016/j.bios.2023.115673
BibTeX
@article{Dong2023,
author = {Dong, Jinying and Wu, Xiaoya and Hu, Qiushi and Sun, Chongsi and Li, Jiahao and Song, Peng and Su, Yan and Zhou, Lei},
title = {An immobilization-free electrochemical biosensor based on CRISPR/Cas13a and FAM-RNA-MB for simultaneous detection of multiple pathogens},
journal = {Biosensors and Bioelectronics},
year = {2023},
doi = {10.1016/j.bios.2023.115673}
}
EUVIMED